A current list of mutations associated with clinical resistance to HIV and the accompanying user notes, regularly revised and disseminated by the IAS–USA Drug Resistance Mutations Group, are epublished in Topics in Antiviral Medicine™. The figures are also available as downloadable PDF.

Request to Reprint Figures

The Drug Resistance Mutations Group welcomes interest in the mutations figures as an educational resource for practitioners and encourages making the material available to as broad an audience as possible. You do not need permission to reprint or distribute the figures for purely educational purposes, for instance, to post in a hospital or share in a classroom.

If you wish to reprint or distribute the mutations figures for commercial purposes, we require that you obtain permission. Please send your request to the IAS–USA via email to info@iasusa.org. Requests to reprint the material should include the name of the publisher or sponsor, the name or a description of the publication in which you wish to reprint the material, the funding organization(s) if applicable, and the intended audience of the publication. If possible, please include a copy or mockup of the proposed reproduction with your request.

Permission will be granted only for requests to reprint the most current version of the mutations figures as posted on the IAS–USA website. Because scientific understanding of HIV drug resistance evolves quickly and the goal of the Drug Resistance Mutations Group is to maintain the most up-to-date compilation of mutations for HIV clinicians and researchers, publishing out-of-date figures is counterproductive. Furthermore, please do not make any changes to the figures, such as by adding labels or significantly adjusting width–height ratio.

If you have any questions or comments about reprints or permissions for use of the mutations figures, please send an email to info@iasusa.org. Even if you are not reprinting for commercial purposes and so do not need permission, we appreciate hearing how far the figures have gone.


The Drug Resistance Mutations Group reviews new data as they emerge and welcomes comments and evidence-based suggestions for revisions (be sure to provide any relevant reference citations). Please submit comments and suggestions to info@iasusa.org.

Related Links

Journal Articles

The IAS–USA has many resources related to HIV drug-resistant mutations.